On Friday, April 7, 2023, a federal judge in Texas (United States) suspended the use of mifepristone, a chemical used in more than half of all chemical abortions, along with another drug, misoprostol.
According to Judge Matthew Kacsmaryk, the U.S. Food and Drug Administration (FDA) overstepped its authority when it approved the use of mifepristone two decades ago. It also accuses the FDA of overstepping its authority by approving a drug with serious side effects for women and facilitating the sale of the drug through the mail system.
The matter went to court through Alliance Defending Freedom, a Catholic group, and the FDA now has one week to appeal Kacsmaryk's decision.
However, practically at the same time, another judge in Washington issued a ruling ordering the FDA not to change the regulation of the abortion pill in any way. The clash between the two judges leads to a confusion that could end up leaving the matter in the hands of the Supreme Court, which a few months ago declared that abortion is not a right protected by the U.S. Constitution.
Practical consequences
Until there is a final ruling that fully clarifies the issue, access to chemical abortion is unclear. However, misoprostol, which is less safe and effective and causes a more painful abortion than using it together with mifepristone, could still be used. Because of this, many believe that women will more frequently go to clinics for surgical abortions.
Abortion clinics are concerned about the situation, as they believe this is the second major attack on "reproductive rights" since Roe v. Wadewas overturned. On the other hand, in States where access to abortion was restricted, virtually nothing will change as a result of this situation.
For his part, U.S. President Joe Biden, along with Vice President Kamala Harris, affirms that the government will fight to defend abortion.
A smear and controversy campaign
Some have accused Alliance Defending Freedom of "judge shopping," saying the ruling is flawed. They also claim that the arguments presented on the side effects of mifepristone ignore the clinical studies conducted. However, the final outcome may not be known until the case moves forward legally and a final ruling is issued.
